Heather Ribaudo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023

ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesHeather ribaudoJudith currierPamelas douglasSteven grinspoonLos angelesMichael luKowa pharmaceuticals america incHarvard medical schoolNational heartBlood instituteNational institutes of healthClinical trials groupData coordinating centerGilead sciences incUniversity of california

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United statesHarvard universityGaryh gibbonsHeather ribaudoPamela douglasMichaelt luHugh auchinclossSteven grinspoonGilead sciences incDuke university department of medicineNeat id foundationA national institutes of healthBlood instituteNational institute of allergyUrsula geller professor of researchNational heart

Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from theA National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from the » The FINANCIAL Health&Beauty

United statesHarvard universityHeather ribaudoSteven grinspoonPamela douglasGaryh gibbonsHugh auchinclossMichaelt luClinical coordinating centerKowa pharmaceuticals america incBlood instituteGilead sciences incUrsula geller professor of researchData coordinating centerDuke university department of medicineHospital cardiovascular imaging research center

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

United statesHarvard universityPamela douglasMichaelt luSteven grinspoonEmily hendersonHeather ribaudoGaryh gibbonsHugh auchinclossDepartment of biostatistics at harvard universityNeat id foundationData coordinating centerClinical trials groupNational heartA national institutes of healthKowa pharmaceuticals america inc

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

United statesSouth africaPuerto ricoHarvard school of public healthJudith currierMichael luEvelynnes fuldaSteven grinspoonEmily hendersonLos angelesPamela douglasHeather ribaudoUniversity of californiaGilead sciencesNational institutes of healthNational institute of allergy